Form D · Other Technology
Novo Health Inc.
Lehi, UT · CIK 0001764909
Offering snapshot reported Nov 27, 2020 · SEC filing
- Reported sold
- $1.85M Offering amount: $1.85M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $7K Reported outside-investor minimum
- First sale
- Nov 13, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 27, 2020 | Initial | $1,851,988 | No comparison | 18 | SEC filing |
| Jan 16, 2019 | Initial | $252,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-381621
Source: Form D, filed Nov 27, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Brodegard | Director |
| Scott Crunkleton | Executive |
| Kevin Jones | Director, Executive |
| Rick Mirell | Executive |
| Marc Watkins | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1881 W. Traverse Parkway Suite E# 208
Lehi, UT, 84043
Lehi, UT, 84043